Proteomics: Harvard University

Total Score People Score Events Score
139 125 30
Date Event Presentation Speakers
January 24, 2016 10th PMWC 2016 Personalized Medicine World Conference TRACK 1 | Raghu Kalluri
April 28, 2014 Companion Diagnostics: From Biomarker Identification to Market Entry Genomics Medicine Raju Kucherlapati
October 17, 2013 14th Annual G Protein-Coupled Receptor (GPCR) Retreat Noncanonical GPCR signaling mechanisms Jean-Pierre Vilardaga
July 21, 2013 54th Annual Short Course on Medical and Experimental Mammalian Genetics C hromosome Struc ture and Function Jeanne Lawrence
Saturday, July 27 Pecking at the Origin of Natural Variation: Insights from Darwin’s Finches and Other Birds Arkhat Abzhanov
Friday, August 2 Reawakening Fetal Hemogl o bin for Therapy: An Old Problem with New Prospects Stuart Orkin
April 6, 2013 AACR Annual Meetings EPIGENETIC TARGETS FOR CANCER Anjana Rao, James E. Bradner
Developmental Origins of Cancer Chairperson: Richard J. Gilbertson, St. Jude Children's Research Hospital, Memphis, TN Stuart H. Orkin
Blood-Based Molecular Analysis of Cancer Daniel A Haber
Intrinsic and Microenvironment-Dependent Adaptive Responses that Regulate Drug Resistance Chairperson: Joan S. Brugge, Harvard Medical School, Boston, MA Joan S Brugge
The Interface Between Development and Cancer Using Model Organisms Chairperson: Michael M. Shen, Columbia University, New York, NY Leonard I. Zon
Emerging Single Cell Technologies in Cancer Research Chairperson: Garry P. Nolan, Stanford University School of Medicine, Stanford, CA Claude Lechene
Mutations in Epigenetic Regulators in Cancer Chairperson: Scott A. Armstrong, Memorial Sloan-Kettering Cancer Center, New York, NY Scott A. Armstrong
Mitotic Checkpoints Driving Cancer Therapeutic Strategies Chairperson: Peter K. Jackson, Genentech, Inc., South San Francisco, CA Timothy J Mitchison
Translational Control and Stress Response Pathways in Cancer Chairperson: Davide Ruggero, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA Karen Cichowski
Developmental and Molecular Origins of Brain Tumors Co-Chairpersons: Suzanne J. Baker, St. Jude Children's Research Hospital, Memphis, TN, and Cameron W. Brennan, Memorial Sloan-Kettering Cancer Center, New York, NY Cameron W Brennan
Synthetic Lethality and Genetic Approaches to Cancer Chairperson: Stephen J. Elledge, Harvard Medical School, Boston, MA Stephen J Elledge
Structural Aberrations in a Thousand Tumors Chairperson: Raju Kucherlapati, Harvard Medical School, Boston, MA Raju Kucherlapati
The Stanley J. Korsmeyer Memorial Symposium: Targeting Cell Death Pathways for Cancer Therapy Chairperson: Anthony G. Letai, Dana-Farber Cancer Institute, Boston, MA Anthony G. Letai
The Origins and Clinical Implications of Precancerous Lesions Chairperson: Cory Abate-Shen, Columbia University Irving Comprehensive Cancer Center, New York, NY Kornelia Polyak
Noncoding RNAs and Cancer Chairperson: Phillip A. Sharp, David H. Koch Institute for Integrative Cancer Research at MIT, Cambridge, MA Jeannie T. Lee
New Cancer Vaccines Chairperson: Glenn Dranoff, Dana-Farber Cancer Institute, Boston, MA Glenn Dranoff
The Origins and Neoplastic Progression of Barrett's Esophagus Co-Chairpersons: Timothy C. Wang, Columbia University Medical Center, New York, NY, and Brian J. Reid, Fred Hutchinson Cancer Research Center, Seattle, WA Frank McKeon
Molecular Basis and Therapeutic Targeting of Bone Metastasis Co-Chairpersons: Yibin Kang, Princeton University, Princeton, NJ, and Matthew R. Smith, Massachusetts General Hospital Cancer Center, Boston, MA Matthew Smith
Molecular and Cellular Determinants of Brain Metastasis Co-Chairpersons: William C. Hahn, Dana-Farber Cancer Institute, Boston, MA, and Joan Massagué, Memorial Sloan-Kettering Cancer Center, New York, NY Rakesh K Jain, William C Hahn
Avatar: Individualized Human Cancer Models in Mice Kwok-Kin Wong
Next-Generation Therapeutic Modeling in Mice Pier Paolo
The Utility of Cancer Cell Line Screens for Modeling Drug Sensitivities Moderator: Jeffrey Settleman, Genentech, Inc., South San Francisco, CA Levi A Garraway
Clinical Trials Based on Mutations versus Histology William R Sellers, Lewis C Cantley
Human Papillomavirus: Beyond Cervical Cancer Chairperson: Maura L. Gillison, The Ohio State University Comprehensive Cancer Center, Columbus, OH Peter M Howley
From Chemistry to the Clinic: Pathways for Drug Discovery and Development, Part 1: Targeting Mechanisms of Therapeutic Resistance Chairperson: Matt V. Lorenzi, Janssen Research & Development, Spring House, PA Kwok-Kin Wong
Credentialing Response Biomarkers for Signal Transduction Inhibitors Chairperson: Neal Rosen, Memorial Sloan-Kettering Cancer Center, New York, NY Anthony G. Letai
Therapeutic Nanotechnology Chairperson: Gregory Lanza, Washington University, St. Louis, MO Omid C Farokhzad
Rational Combination Therapies in Cancer Chairperson: Gordon B. Mills, The University of Texas MD Anderson Cancer Center, Houston, TX Scott A. Armstrong
The Next Frontier in Targeted Therapy for Melanoma Chairperson to be announced Lynda Chin
New Paradigms in Molecular Pharmacology Chairperson: Angela N. Koehler, Broad Institute of MIT and Harvard, Cambridge, MA James E. Bradner
Metabolism and Signaling in Cancer Chairperson: Eyal Gottlieb, The Beatson Institute for Cancer Research, Glasgow, United Kingdom Nika N. Danial
Immune Modulation in the Tumor Microenviroment Chairperson: James P. Allison, Memorial Sloan-Kettering Cancer Center, New York, NY Raghu Kalluri
Cancer Imaging in Mice and Men Andrew L. Kung, Dana-Farber Cancer Institute, Boston, MA Andrew Kung
2-Oxoglutarate-Dependent Dioxygenases as Targets of Cancer-Causing Mutations and Cancer Therapeutics William G. Kaelin, Jr., Dana-Farber Cancer Institute, Boston, MA William G Kaelin
Tumor-Secreted Factors Chairperson: David C. Lyden, Weill Cornell Medical College of Cornell University, New York, NY Xandra O Breakefield
Autocrine Activation of MET and Strategies to Overcome Adaptation for the Targeted Therapy of Acute Myeloid Leukemia A. Thomas Look, Dana-Farber Cancer Institute, Boston, MA Thomas A. Look
Stapled Peptides as Next-Generation Therapeutics Gregory L. Verdine, Harvard University, Cambridge, MA Gregory L Verdine
Prognostic and Predictive Biomarkers of Triple-Negative Breast Cancer Andrea L. Richardson, Brigham and Women's Hospital, Boston, MA Andrea L Richardson
Cancer Omics Beyond the Genome Sunney Xie
16th Annual Grant Writing Workshop Building Presence and Leadership through Empowered Communication Co-Chairpersons: Martine J. Piccart, Institut Jules Bordet, Brussels, Belgium, and Victoria M. Richon. Epizyme, Inc., Wellesley Hills, MA Kornelia Polyak
Patient-Derived Xenograft Models of Cancer: Where Are We Going? Chairperson: Matthew J. Ellis, Washington University Siteman Cancer Center, St. Louis, MO Tan Ince
WICR Career Mentoring Session Joan S Brugge
July 15, 2012 53rd Annual Short Course on Medical and Experimental Mammalian Genetics Evening Lecture | Title TBD David Altshuler
Title TBD Paul Ridker
Pecking at the Origin of Natural Variation: Insights from Darwin’s Finches and Other Birds Arkhat Abzhanov
June 20, 2011 Cancer Proteomics 2011 - Systems Biology, Developmental Models and Data Integration Interactome networks & human disease Marc Vidal
May 8, 2011 Omics Meets Cell Biology (E1) Large-Scale Analyses of Signaling Networks Norbert Perrimon
September 15, 2010 8th International Conference on Bone Morphogenetic Proteins Title pending Herb Lin
June 17, 2010 Institute of Structural and Molecular Biology 4th Symposium Drugging Oncogenic Transcription Factors Gregory Verdine
April 30, 2010 Drug Story KEYNOTE PRESENTATION Joshua LaBaer
April 6, 2010 IBCs 5th Annual China 2010 Pharmaceutical R&D Summit China's Healthcare Reform: Implications for the Industrial Sectors Yuan-Li Liu
August 5, 2009 Targets in Context - Linking Targets to Diseases Agenda Michael Foley, Ph.D. Build-Couple-Pair Strategy for Diversity-Oriented Synthesis Yields a Unique Compound Collection for Probe Development and Drug Discovery Michael Foley
In Vivo Chemical Screening in Zebrafish Joanna Yeh
July 22, 2009 Eighth International Congress on the Future of Breast Cancer Targeting Metastases Andrea L Richardson, Shyamala Maheswaran
Triple-Negative Breast Cancer Andrea L Richardson
December 4, 2008 BIT Life Sciences 2nd Annual World Congress of Gene-2008 (WCG 2008) TBD Yu-Li Wang
Co-Chair :Track 2-8 Zhen Y. Jiang
Analyzing Insulin Signaling Networks and Metabolic Functions Using Quantitative Proteomics Approach :Track 2-8 Zhen Y. Jiang
Oral Delivery of Glucan Encapsulated siRNA to Macrophages Targeting Map4K4 Attenuates Systemic Inflammation :Track 2-8 Myriam Aouadi
Developmental Origin of Adipose Tissue: Novel Role of Bone Morphogenetic Proteins in Adipogenesis and Energy Metabolism :Track 2-8 Yu-Hua Tseng
Title: TBD : Track 4-4 Jing X. Kang
November 4, 2008 Advances in Research Conference: Human Disorders of Protein Processing: Mechanisms, Consequences, and Therapeutic Implications Biophysics of Protein Folding Lila Gierasch
Role of Glycans in ER Quality Control Dan N Hebert
Modulation of Proteasome Activity by Stress Daniel Finley
September 29, 2008 Biomarker Discovery Summit 2008 High-Throughput Cell-Based Studies and Protein Microarrays for Biomarker and Target Discovery Joshua LaBaer
September 29, 2008 Metabolic Biomarkers High-Throughput Cell-Based Studies and Protein Microarrays for Biomarker and Target Discovery Joshua LaBaer
July 19, 2008 22nd Annual Symposium of The Protein Society Concurrent Morning Symposia 2: Proteomics [sponsored by Merck Research Laboratories] Claude Lechene
Concurrent Morning Symposia 12: Systems Biology Josh LaBaer
May 7, 2008 Advances in Microarray Technology Functional Genomic Driving Individualized Medicine Towia Libermann
April 30, 2008 RNAi World Congress Dual Role for Argonaute Proteins in microRNA Processing and Post-Transcriptional Regulation of microRNA Expression Sven Diederichs
RNAi: From Mechanism to Medicine Craig Mello
April 27, 2008 Difficult to Express Proteins Dual-Promoter Lentiviral System allows Inducible Igor Kramnik
January 6, 2008 PROTEIN FOLDING DYNAMICS Hydrophobic Clusters and beta/alpha-hairpin Clamps: Sequence Effects on Folding, Stability and Structure in TIM Barrel Proteins Bob Matthews
January 6, 2008 Structural Genomics and its Applications to Chemistry, Biology and Medicine Following Session is for Structural Biology (J1) Macromolecular Dynamics: Experiment and Theory Gerhard Wagner
Following Session is for Structural Biology (J1) Membrane Protein Structure James Jeiwen Chou
Pushing the Limits of Structural Biology II: Advances in Methodologies for Structure Determination (Joint) Gerhard Wagner
Proteomics and Protein Assemblies/Networks Alexander B. Sigalov
December 13, 2007 Stem Cells 2007 TBC David T Scadden
December 1, 2007 47TH American Socieity of Cell Biology Design Principles for Connecting the Genome to the World I Philips, C. Ajo-Franklin
Minisymposium 1A:Cell Biology Working Group: Challenges in Cell Biology—The Nature of Cytoplasm Timothy J Mitchison
Interphase and Mitotic CDKs Follow Kinetically Distinct Paths to Activation in Human Cells. C. Zhang
*Single-Molecule Analysis Reveals the Distribution of Potential vs. Active DNA Replication Origins in Human Cells R. Lebofsky
Cell Matrix Interactions (Room 140A) Yu-Li Wang
Advances in Bone Cell Molecular Biology: Epigenetic Control Jane Lian, Gary S Stein
CLASPs Clutching Microtubule Networks (Room 209 B/C) David Van Vactor
At the Limits: Optical Methods for Single Molecules, Cells, and Organisms Jennifer Waters, Samara Rech-Peterson
High Performance Image Analysis and Photomanipulative Techniques for Jeffrey Nickerson
Building the Cell (Room 140B) L Mahadevan
Systems Biology of Receptor Tyrosine Kinase Networks (Room 206) Peter K. Sorger
Public Service Award Presentation Matthew Michael
Primary Role for Centrosome Proteins in Cilia Formation and Cilia-associated Disorders B Delaval, L Covassin Barberis, N Lawson, Stephen J Doxsey
Cell-Type Variation in Responses to Anti-mitotic Drugs. C Loy, J Orth, C Shamu, M Tsui, V Yanamadala, Timothy J Mitchison
Fluorescence Correlation Spectroscopy Workshop Daniel Needham
Actin Disassembly by Whole-Filament Destabilization.v H Kueh, W M Brieher, Timothy J Mitchison
How Does Thrombospondin Induce CNS Synaptogenesis? J. T. Lawler
Identifying Matrix- and Growth Factor-induced Transcriptional Dichotomies by Stochastic Sampling. K A Janes, Joan Brugge
High-Tech Cell Biology Kendall Knight
DNA Damage Signaling Events Revealed by 4Pi Microscopy. Kendall Knight, Brian T Bennett
Novel Microscopy Methodology to Examine DNA Damage Signaling and Repair. Brian T Bennett
Heterochromatin Formation in Fission Yeast. M Huarte, Yang Shi
Anti-fi brotic Property of CTGF siRNA in the Liver via Targeted Delivery to Hepatic Stellate Cells. David Roger Brigstock, C Lawrencia
Mallory Body Formation in the Livers of Drug-primed Mice Is Regulated by an Epigenetic Mechanism Jian Li
Myosin-activated Random Stress Fluctuations in the Actin Cytoskeleton David Weitz
Cytoplasmic Dynein Is a Better Navigator than Kinesin on Tau-decorated Microtubules. J. L. Ross
Determining the Molecular Architectures of Cellular Machines by Satisfaction of Spatial Restraints: The Nuclear Pore Complex. Adrian Salic
Posters Displayed:Monday Joan Brugge
Amaxa GmbH: Alan D Andrea
Post-Cytokinetic DNA Segregation by ATPases That Form DNA-Conducting Channels Tom A Rapoport, N L Sullivan, K Marquis
Maintenance of Polarity and Cell Shape in Vibrio cholerae Matthew K Waldor
Biochemical Characterization of Type III-secreted Bacterial Acetyltransferases J Orth
November 4, 2007 AACR Centennial Conference: Translational Cancer Medicine Plenary Session 2: Proteomics, Genomics and Biomarker Discovery Gregory L Verdine
Plenary Session 6: Clinical Intervention and Populations Outcomes: Global Strategies Rakesh K Jain
July 28, 2007 From Unfolded Proteins in the Endoplasmic Reticulum to Disease Carbohydrate-mediated protein maturation and quality control in the endoplasmic reticulum Dan N Hebert
A chemoproteomic approach implicates eukaryotic elongation factor 2 kinase in ER stress-induced cell death Marta Lipinski
ER Dysfunction in Obesity and Type 2 Diabetes Gokhan Hotamisligil,
July 7, 2007 Protein Kinases and Protein Phosphorylation Signal transduction by Stress-activated MAP Kinases Roger Davis
ERK2 signaling through DEF domain interactions induces epithelial-to-mesenchymal transition (EMT) in breast epithelial cells Christopher Dimitri
Regulation of neuronal death by protein kinase pathways Azad Bonni
June 23, 2007 Mechanism and Regulation of Prokaryotic Transcription “Structural mechanism for the cascade of events that comprise promoter escape by T7 RNAP” Craig T Martin
“Determining the distribution of E. coli RNAP and associated proteins across transcribed regions in vivo” Joe Wade
“Lambda Q interacts with the beta flap” Bryce E Nickels
“RNA polymerase-associated proteins control virulence in Francissella tularensis” Simon Dove
“Probing transcription factor dynamics at the single molecule level in a living cell” Gene Wei Li
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.